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• Magnetic-activated cell sorting (MACS) isolates full length expression of scm-MHCII mutants in the library 
magnetically binding to the c-myc tag
Protein Engineering Potential Inhibitor of Detrimental Immune Responses
Nathaniel L Blalock, Liang Fang, Eric T. Boder
Chemical and Biomolecular Engineering Department of the University of Tennessee: Knoxville
A b s t r a c t
F u t u r e  C o n s i d e r a t i o n s
1 .  I n t r o d u c t i o n
• Presentation of Antigenic Proteins
1. Extracellular antigenic proteins enter immune cells through endocytosis
2. Lysosomes digest antigenic proteins 
3. The resultant peptide fragments are loaded onto MHCII then presented on the 
surface of the immune cell
• CD4+ T cell recognition requires full-length, functional scm-MHCII to inhibit immune response 
by tightly binding with CD4+ T cells
• Goals:
1. Apply directed evolution to engineer stable scm-MHCII mutants.
2. Isolate and characterize stable mutants demonstrating potential as a highly 
specific inhibitor of T cell-mediated immune responses to treat a variety of 
auto-immune diseases.
On the surface of immune cells, class II major histocompatibility complex proteins 
(MHCII) present antigenic peptides for CD4+ T cell recognition, which initiate a variety of 
antigen-specific immune responses such as antibody response or cytotoxic T cell 
activation. In people with with auto-immune diseases including but not limited to type 1 
diabetes, multiple sclerosis, and rheumatoid arthritis, detrimental immune responses occur 
after the presentation of antigenic peptides. A single-chain, minimal MHCII (scm-MHCII) has 
been designed to retain its function as an antigen-presenting protein with a simplified 
structure that can be easily produced and manipulated in a laboratory by recombinant 
microbial expression. By applying directed evolution and selection for protein stability 
quantified using yeast surface display (YSD), we have engineered a mutant library which 
may contain highly stable mutants capable of functioning as a highly specific inhibitor of T 
cell-mediated immune responses with the potential to be applied to treating a variety auto-
immune diseases. 
5 .  I m p r o v i n g  s c m - M H C I I  S t a b i l i t y
6 .  S c r e e n i n g  L i b r a r y  f o r  F u l l  L e n g t h  E x p r e s s i o n
Cell separation strategies using MACS® Technology - USA. 
• During yeast surface display, a flow cytometer quantifies the intensity of fluorescent 
antibodies bound to scm-MHCII displayed by induced EBY100.
• Fluorescence indicates the partial or complete display of simplified HLA-DR4 depending 
on the specific fluorophore detected.
4 .  Q u a n t i f y i n g  S t a b i l i t y
Homologous Recombination and Yeast Surface Display
“High-Throughput Engineering and Analysis of Class II Mhc/Peptide Binding” by Wei Jiang. 
https://repository.upenn.edu/edissertations/419/. Accessed January 21, 2020. 




2 .  C r e a t i n g  M u t a n t  L i b r a r y
• Error-prone polymerase chain-reaction cycles produces scm-MHCII mutants
Boder, et al. Yeast surface display of a noncovalent MHC class II heterodimer 
complexed with antigenic peptide. Biotechnology and Bioengineering. (2005)
Yeast Shuttle Vector and
scm-MHCII Construct 
3 .  C h a r a c t e r i z i n g  L i b r a r y
• Mutant library contains 2-5x10^5 scm-MHCII mutants
• Significance: library includes all possible single amino acid 
change scm-MHCII mutants
• Successful mutagenesis: average 4.5 nucleotide mutations per 700 base pairs 
of scm-MHCII obtained from Sanger sequencing of clones
Positive display with PCT302 Initial scm-MHCII Display
• Yeast surface display quantifies improvement of scm-MHCII mutants
There is a possible increase in stability indicated by 
the slightly more substantial “shoulder” of cells.
C o n c l u s i o n s
• The combinatorial library contains the diversity required to represent all single amino acid change 
mutants
• After 4 rounds of MACS screening, the more stable mutants have been isolated.
• Use fluorescent-assisted cell sorting (FACS) to isolate the most stable mutants from MACS screens
• Plate mutants and sequence monoclonal colonies
• Identify desirable mutations
• Investigate combinations of desirable, characterized mutations
• Engineer stabilized scm-MHCII fto possess a high affinity for CD4+ T cells
A c k n o w l e d g e m e n t s
• Genomic Core, University of Tennessee 
• National Institute of General Medical Sciences 1R15GM122326
• Homologous recombination reintroduces scm-MHCII mutants into 















• Establishing positive and initial scm-MHCII display with histograms
After 4 Rounds of MACS
There is a significant increase in 
stability in the cell population from 
the screened library indicated by the 
tail of cells with a substantial 
increase in fluorescent intensity.
